The gap between medical innovation and patient access is widening. Whether it’s a new drug or a digital therapeutic (DTx), high costs and fragmented reimbursement models often keep these tools out of reach.
ASCERTAIN (Access2Meds) is here to fix that. The project is developing open-access tools to help policymakers and manufacturers define fair pricing and sustainable reimbursement across Europe.
Our Role: Trust and Data Governance
Innovation without trust is a non-starter. As the lead for Work Package 2 (Data Management, Privacy, and Ethics), Chino.io is the backbone of the project’s data integrity.
We aren't just "checking boxes." We are ensuring that the clinical and economic data driving these new pricing models is handled with the highest standards of GDPR compliance and cybersecurity.
Our job is to make sure the researchers and clinical partners can focus on what they do best—improving healthcare—without getting bogged down by the complexities of data regulation.
Why It Matters
As I always say: "Compliance is an enabler, not a blocker." By partnering with world-class institutions like Erasmus University Rotterdam and the University of Oslo, we are helping build a more equitable European healthcare ecosystem. We are ensuring that the future of medicine is not just technologically advanced, but also affordable and safe for every citizen.
Stay tuned for more updates as we redefine market access in Europe!
Streamline Your Compliance With Chino.io Today
Discover our
Templates
Read our Latest Industry Insights
Discover insights from our expert writers.
